NCT05473208

Brief Summary

A randomized control trial will be conducted, for evaluating the effectiveness of the implementation of a lower back assistive exoskeleton on the caregivers working in nursing homes.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P50-P75 for not_applicable healthy

Timeline
Completed

Started Oct 2022

Longer than P75 for not_applicable healthy

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 20, 2022

Completed
5 days until next milestone

First Posted

Study publicly available on registry

July 25, 2022

Completed
3 months until next milestone

Study Start

First participant enrolled

October 11, 2022

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2023

Completed
1.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

January 5, 2023

Status Verified

January 1, 2023

Enrollment Period

12 months

First QC Date

July 20, 2022

Last Update Submit

January 4, 2023

Conditions

Keywords

Low back painExoskeletonCaregiverNursing homeMusculoskeletal diseaseQuality of life

Outcome Measures

Primary Outcomes (4)

  • Change from baseline Pain Intensity at 3 months

    Average pain intensity during the last 7 days in a Numerical Rating Scale for pain ranging from 0 (complete absence of pain) to 10 (worst imaginable pain). This information will be collected for pain in the low back, neck, shoulders and wrists/hands

    At Baseline and at 3 months

  • Change from baseline Pain Intensity at 6 months

    Average pain intensity during the last 7 days in a Numerical Rating Scale for pain ranging from 0 (complete absence of pain) to 10 (worst imaginable pain). This information will be collected for pain in the low back, neck, shoulders and wrists/hands

    At Baseline and at 6 months

  • Change from baseline Pain Intensity at 9 months

    Average pain intensity during the last 7 days in a Numerical Rating Scale for pain ranging from 0 (complete absence of pain) to 10 (worst imaginable pain). This information will be collected for pain in the low back, neck, shoulders and wrists/hands

    At Baseline and at 9 months

  • Change from baseline Pain Intensity at 12 months

    Average pain intensity during the last 7 days in a Numerical Rating Scale for pain ranging from 0 (complete absence of pain) to 10 (worst imaginable pain). This information will be collected for pain in the low back, neck, shoulders and wrists/hands

    At Baseline and at 12 months

Secondary Outcomes (9)

  • Usability measured by System Usability Scale

    Baseline, month 3, month 6, month 9, post intervention

  • User Satisfaction measured by Quebec User Evaluation of Satisfaction with Assistive Technology

    Baseline, month 3, month 6, month 9, post intervention

  • Self-reported work ability by Work Ability Index

    Baseline, month 3, month 6, month 9, post intervention

  • Borg's CR-10 scale for perceived physical exertion at work

    Baseline, month 3, month 6, month 9, post intervention

  • Muscular resistance of the trunk muscles measured by the "Shirado-Ito" test

    Baseline, month 3, month 6, month 9, post intervention

  • +4 more secondary outcomes

Study Arms (2)

Control Group

NO INTERVENTION

Participants randomly assigned to control group will not wear an exoskeleton during working hours.

Exoskeleton Group

EXPERIMENTAL

Participants randomly assigned to exoskeleton group will be given instructions and explanations on how to use/adjust/loosen the exoskeleton, and after a period of familiarisation, they will be wearing an exoskeleton during their working hours for a period of one year.

Device: Exoskeleton

Interventions

Lumbar assistive exoskeleton evaluation

Exoskeleton Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • nursing home caregivers

You may not qualify if:

  • pregnancy
  • presence of condition that prevents from the use of a lumbar exoskeleton

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

IFAS/GUFE Centro Asistencial Leioa

Leioa, Bizkaia, 48940, Spain

RECRUITING

IFAS/GUFE Centro Asistencial Elorrio

Elorrio, Vizcaya, 48230, Spain

RECRUITING

MeSH Terms

Conditions

Low Back PainMusculoskeletal PainMusculoskeletal Diseases

Interventions

Exoskeleton Device

Condition Hierarchy (Ancestors)

Back PainPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsMuscular Diseases

Intervention Hierarchy (Ancestors)

Equipment and Supplies

Study Officials

  • Ana Rodriguez Larrad, PhD

    Professor

    STUDY DIRECTOR

Central Study Contacts

Ana Rodriguez Larrad, PhD

CONTACT

Maialen Aiestaran, MsC

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
The investigators in charge of doing the statistical analysis and assessing the outcome measures (e.g., physical performance tests) will be blinded to group allocation. Due to the characteristics of the study (use of the exoskeleton during working hours) blinding of the participants is not possible.
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

July 20, 2022

First Posted

July 25, 2022

Study Start

October 11, 2022

Primary Completion

September 30, 2023

Study Completion

December 31, 2024

Last Updated

January 5, 2023

Record last verified: 2023-01

Locations